Doctor profile · Federal record
Dr. Peter Graze, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Annapolis, MD
- NPI 1669400784
- Accepts Medicare
- MIPS 99.8 / 100 · 2023
- 55 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2003 Medical Pkwy, Suite 210
Annapolis, MD 214017992
(410) 573-5300
fax (410) 266-9645 - Mailing address
-
Po Box 12622
Belfast, ME 049154017
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- December 3, 2013
- Year of graduation
- 1971 — 55 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Maryland #D0016364
- Medicaid
- MD #316651100
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1669400784. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
62,702
Distinct HCPCS
10
Medicare allowed
$1,742,609
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 15,000 | 18 | $54 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 11,880 | 14 | $47 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 10,710 | 11 | $1 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 10,460 | 16 | $3 | |
J0185 |
Injection, aprepitant, 1 mg | 4,550 | 21 | $2 | |
J0897 |
Injection, denosumab, 1 mg | 2,160 | 13 | $23 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 2,000 | 19 | $21 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,160 | 52 | $0 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,020 | 251 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 542 | 217 | $134 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 1,276. This provider delivers 49× the peer median.Open Payments
Industry payments received
All-time total
$1,407
Transactions
38
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| SERVIER PHARMACEUTICALS LLC | 3 | $156.76 | |
| Novartis Pharmaceuticals Corporation | 5 | $132.11 | |
| ABBVIE INC. | 4 | $107.24 | |
| Celgene Corporation | 5 | $101.15 | |
| Merck Sharp & Dohme LLC | 4 | $94.40 | |
| Medtronic, Inc. | 2 | $74.14 | |
| PFIZER INC. | 3 | $71.05 | |
| AstraZeneca Pharmaceuticals LP | 2 | $56.07 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $51.81 | |
| Adaptive Biotechnologies Corporation | 2 | $49.27 | |
| Silk Road Medical, Inc. | 1 | $42.31 | |
| Gilead Sciences, Inc. | 2 | $37.34 | |
| Edwards Lifesciences Corporation | 1 | $35.76 | |
| Janssen Biotech, Inc. | 1 | $34.33 | |
| GlaxoSmithKline, LLC. | 1 | $33.80 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
300
Patients
29
Total drug cost
$1,278,303
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Allopurinol | Generic | 38 | 14 | $563 |
| Prednisone | Generic | 29 | 0 | $256 |
| Pomalyst (Pomalidomide) | Brand | 21 | 0 | $399,541 |
| Ondansetron Hcl | Generic | 20 | 15 | $172 |
| Xarelto (Rivaroxaban) | Brand | 20 | 0 | $30,415 |
| Baclofen | Generic | 19 | 0 | $336 |
| Eliquis (Apixaban) | Brand | 19 | 0 | $25,837 |
| Revlimid (Lenalidomide) | Brand | 19 | 0 | $321,851 |
| Venclexta (Venetoclax) | Brand | 19 | 0 | $197,606 |
| Alprazolam | Generic | 17 | 0 | $209 |
Frequently asked questions
What is Dr. Peter Graze's medical specialty?
Dr. Peter Graze practices Hematology & Oncology Physician in Annapolis, MD.
Where does Dr. Peter Graze practice?
Dr. Peter Graze practices at 2003 Medical Pkwy, Annapolis, MD 214017992. Office phone: 4105735300.
What is Dr. Peter Graze's NPI?
Dr. Peter Graze's National Provider Identifier (NPI) is 1669400784, issued by NPPES.
Does Dr. Peter Graze accept Medicare assignment?
Yes. Dr. Peter Graze accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Peter Graze commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138). Source: CMS Medicare Physician & Other Practitioners file.